Absence of changes in antidiuretic hormone, angiotensin II, and atrial natriuretic peptide with clozapine treatment of polydipsia-hyponatremia: 2 case reports

Journal of Clinical Psychiatry

Volumn 59, Issue 8, 1998, Pages 415-419

  Verghese, Cherian ^e   Abraham, George ^a   Nair, Chand ^a   Stanilla, Joseph K ^a   De Leon, Jose ^b   Phillips, M Ian ^c   Simpson, George M ^d  

^a Norristown State Hospital   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CLOZAPINE; HALOPERIDOL; PROLACTIN; SODIUM ION; VASOPRESSIN;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; HUMAN; HYPONATREMIA; MALE; OSMOREGULATION; POLYDIPSIA; PRIORITY JOURNAL; PROLACTIN RELEASE; RELATIVE DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHIZOPHRENIA; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; URINE OSMOLALITY; URINE VOLUME; VASOPRESSIN RELEASE; WEIGHT GAIN;

EID: 0031817793     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0803     Document Type: Article

References (24)

1. de Leon J, Verghese C, Tracy J, et al. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994;35:408-419
2. Vieweg WV, Rowe WT, David JJ, et al. Self-induced water intoxication and psychosis (SIWIP): subcategory of the syndrome of inappropriate antidiuresis (SIAD). Psychiatr Med 1987;4:277-290
3. Delva NJ, Crammer JL, Jarzylo SB, et al. Vasopressin in chronic psychiatric patients with primary polydipsia. Br J Psychiatry 1990;157:703-712
4. Alexander RC, Karp BI, Thompson S, et al. A double-blind, placebo-controlled trial of demcclocycline treatment of polydipsia-hyponatremia in chronically psychotic patients. Biol Psychiatry 1991;30:417-420
5. Verghese C, de Leon J, Simpson GM. Neuroendocrine factors influencing polydipsia psychiatric patients: an hypothesis. Neuropsychopharmacology 1993;9:157-166
6. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988;318:397-403
7. Lee HS, Kwon KY, Alphs LD, et al. Effect of clozapine on psychogenic polydipsia in chronic schizophrenia. J Clin Psychopharmacol 1991;11: 222-223
8. Verghese C, de Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull 1996; 22(3):455-464
9. Fitzsimons JT, Simons BJ. The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst. J Physiol (Lond) 1969;203:45-57
10. Phillips PA, Rolls BJ, Ledingham JGG, et al. Angiotensin II-induced thirst and vasopressin release in man. Clin Sci (Colch) 1985;68:669-674
11. Heidbreder E, Bahner U, Hess M, et al. Thirst regulation in endstage renal disease. Klinische Wochenschrift 1990;68:1127-1133
12. Goldstein JA. Captopril in the treatment of psychogenic polydipsia [letter]. J Clin Psychiatry 1986;47:99
13. Lawson WB, Williams B, Pasion R. Effects of captopril on psychosis and disturbed water regulation. Psychopharmacol Bull 1988;24:176-178
14. Vieweg WV, Cary RM, Godleski LS, et al. The syndrome of psychosis, intermittent hyponatremia, and polydipsia: evidence for diurnal volume expansion. Psychiatr Med 1990;8(4):135-144
15. Horrobin DF. Prolactin as a regulator of fluid and electrolyte metabolism in mammals. Fed Proc 1980;39(8):2567-2570
16. Simpson GM, de Leon J, Nair C, et al. Double-blind clozapine in treatment-resistant schizophrenia. Poster presentation at the 34th annual meeting of the American College of Neuropsychopharmacology; Dec. 11-14, 1995; San Juan, Puerto Rico
17. Richards AM, Nicholls MG, Espiner EA, et al. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens 1986;A8(2):153-166
18. Bayliss PH. Regulation of vasopressin secretion. Baillieres Clin Endocrinol Metab 1986;3(2):313-330
19. Hoffman WE, Phillips MI, Kimura B. Plasma atrial natriuretic polypeptide and angiotensin II in rats during anesthesia and volume loading. Anesth Analg 1989;68(11):40-45
20. 2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res 1992;586(2):289-294
21. Hersen M, Barlow DH. Single-Case Experimental Designs: Strategies for Studying Behavior Change. New York, NY: Pergamon Press; 1976
22. Ohsawa H, Kishimoto T, Shimayoshi N, et al. Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients. Acta Psychiatr Scand 1993;88:130-134
23. Eisner GM, Yamaguchi I, Felder RA, et al. Role of renal dopamine D1 receptors in natriuresis induced by calcium channel blockers. Am J Physiol 1994;267(6 pt 2):F965-F970
24. Kushnir M, Schattner A, Ezri T, et al. Case report: schizophrenia and fatal self-induced water intoxication with appropriately-diluted urine. Am J Med Sci 1990;300:385-387